Serum Cystatin C and emphysema: Results from the National Health and Nutrition Examination Survey (NHANES)

Lung

Volumn 190, Issue 3, 2012, Pages 283-290

  Rokadia, Haala K ^a   Agarwal, Shikhar ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease; Cystatin C; Emphysema; National Health and Nutrition Examination Survey; Smoking

Indexed keywords

C REACTIVE PROTEIN; COTININE; CYSTATIN C;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC BRONCHITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EMPHYSEMA; ENVIRONMENTAL PARAMETERS; ENVIRONMENTAL TOBACCO SMOKE EXPOSED; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; SMOKING; UNITED STATES;

ADULT; AGED; BRONCHITIS, CHRONIC; C-REACTIVE PROTEIN; CYSTATIN C; EMPHYSEMA; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; PREVALENCE; SMOKING; TOBACCO SMOKE POLLUTION; UNITED STATES;

EID: 84863445087     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-012-9374-z     Document Type: Article

References (43)

1. Jannoff A, Sloan B, Weinbaum G et al (1977) Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 115:461-478
2. Owen CA, Campbell EJ (1999) The cell biology of leukocytemediated proteolysis. J Leukoc Biol 65:137-150
3. Lesser M, Padilla ML, Cardozo C (1992) Induction of emphysema in hamsters by intratracheal instillation of cathepsin B. Am Rev Respir Dis 145:661-668
4. Chughtai B, O'Riordan TG (2004) Potential role of inhibitors of neutrophil elastase in treating diseases of the airway. J Aerosol Med 17:289-298
5. Chua F, Laurent GJ (2006) Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 3:424-427
6. Lungarella G, Cavarra E, Lucattelli M, Martorana PA (2008) The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol 40:1287-1296
7. Owen CA (2008) Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis 3:253-268
8. Abboud RT, Vimalanathan S (2008) Pathogenesis of COPD. Part 1. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 12:361-367
9. Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis, and therapy in cancer. Oncol Rep 5:1349-1361
10. Chapman HA, Stone OL (1984) Comparison of live human neutrophils and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors. J Clin Invest 74:1693-1700
11. Abbott DE, Margaryan NV, Jeruss JS et al (2010) Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther 9:23-30
12. Meng L, Yang Y, Qi LT, Wang XJ, Xu GB, Zhang BW (2011) Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function. J Nephrol. doi:10.5301/jn. 5000020
13. Bevc S, Hojs R, Ekart R, Gorenjak M, Puklavec L (2011) Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. Ther Apher Dial 15:261-268
14. Kottgen A, Selvin E, Stevens LA et al (2008) Serum cystatin C in the United States: the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 51:385-394
15. Kyhse-Andersen J, Schmidt C, Nordin G et al (1994) Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40:1921-1926
16. Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221-226
17. Zore I, Krasovec M, Cimerman N et al (2001) Cathepsin B/Cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem 382:805-810
18. Poteryaeva ON, Falameyeva OV, Korolenko TA et al (2000) Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. Drugs Exp Clin Res 26:301-306
19. Krepela E, Prochazka J, Karova B, Cermak J, Roubkova H (1998) Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma 45:318-331
20. Kos J, Werle B, Lah T, Brunner N (2000) Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 15:84-89
21. Werle B, Schanzenbacher U, Lah TT et al (2006) Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis. Oncol Rep 16:647-655
22. Buttle DJ, Burnett D, Abrahamson M (1990) Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation. Scand J Clin Lab Invest 50:509-516
23. Luthgens K, Ebert W, Trefz G, Gabrijelcic D, Turk V, Lah T (1993) Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. Cancer Detect Prev 17:387-397
24. Werle B, Sauckel K, Nathanson CM et al (2003) Cystatins C, E/M, and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem 382:281-287
25. Warfel AH, Cardozo C, Yoo OH, Zucker-Franklin D (1991) Cystatin C and cathepsin B production by alveolar macrophages from smokers and nonsmokers. J Leukoc Biol 49:41-47
26. Altiok O, Yasumatsu R, Bingol-Karakoc G et al (2006) Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 173:318-326
27. Centers for Disease Control and Prevention (2010) NHANES-National Health and Nutrition Examination Survey homepage. Available at http://www.cdc.gov/nchs/ nhanes.htm/. Accessed 3 August 2010
28. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation classification and stratification. Ann Intern Med 139:137-147
29. Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038-2047
30. Selvin S, Manzi J, Stevens LA et al (2007) Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 50:918-926
31. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F (2010) Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human disease. Pharmacol Rev 62:726-759
32. Abrahamson M (1994) Cystatins. Methods Enzymol 244:685-700
33. Salgado JV, Neves FA, Bastos MG et al (2010) Monitoring renal function: measured and estimated glomerular filtration rates-a review. Braz J Med Biol Res 43:528-536
34. Lafarge JC, Naour N, Clement K, Guerre-Millo M (2010) Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 92:1580-1586
35. Shlipak MG, Marnak MJ, Katz R et al (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352:2049-2060
36. Finlay GA, Russell KJ, McMahon KJ et al (1997) Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52:502-506
37. Henskens YM, Veerman EC, Amerongen AV (1996) Cystatins in health and diseases. Biol Chem Hoppe Seyler 377:71-86
38. Abrahamson M, Alvarez-Fernandez M, Nathanson CM (2003) Cystatins. Biochem Soc Symp 70:179-199
39. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG (1995) Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152:1666-1672
40. Takeyabu K, Betsuyaku T, Nishimura M et al (1998) Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J 12:1033-1039
41. Chapman HA, Reilly JJ, Yee R, Grubb A (1990) Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis 141:698-705
42. Sloane BF, Rozhin J, Robinson D, Honn KV (1990) Role for cathepsin B and cystatins in tumor growth and progression. Biol Chem Hoppe Seyler 371:193-198
43. Woischnik M, Bauer A, Aboutaam R et al (2008) Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis. Eur Respir J 31:1197-1204